AnaptysBio Inc (ANAB): Next-Year EPS Estimate 30.63%
As of 2026-04-30, AnaptysBio Inc (ANAB) has a next-year EPS growth estimate of 30.63%.
On 2026-04-28, analyst consensus for ANAB's next-year EPS growth shifted from 46.11% to 30.63% — a negative change of 15.48 percentage points. The revised estimate has been sustained across 3 subsequent trading sessions. Current-year growth is projected at -729.37%.
Current Snapshot
- Sector
- Healthcare
- Industry
- Biotechnology
- EPS growth next year
- 30.63%
- EPS growth this year
- -729.37%
- EPS next quarter (est)
- -$0.72
- Last price
- $65.73
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-04-30 | 30.63% | -729.37% | -$0.72 | $65.73 |
| 2026-04-29 | 30.63% | -729.37% | -$0.72 | $62.34 |
| 2026-04-28 | 30.63% | -729.37% | -$0.72 | $66.11 |
| 2026-04-27 | 46.11% | -728.96% | -$0.72 | $66.59 |
Recent News
Screen Performance
Aggregate stats across all 1761 tickers our top-EPS-revision screen has flagged over the past 64 days.
- Median return since detection
- +5.1%
- % of tickers in the green
- 62%
- Median return on winners
- +17.5%
- Large revisions captured
- 746
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Frequently Asked Questions
What is AnaptysBio Inc's next-year EPS growth estimate?▾
As of 2026-04-30, AnaptysBio Inc (ANAB) has a next-year EPS growth estimate of 30.63%, based on analyst consensus.
When was the latest EPS estimate revision for ANAB?▾
The most recent revision occurred on 2026-04-28, when analysts adjusted the next-year EPS growth estimate from 46.11% to 30.63%.
What sector and industry does AnaptysBio Inc belong to?▾
AnaptysBio Inc operates in the Healthcare sector, specifically the Biotechnology industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. ANAB appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. AnaptysBio Inc (ANAB) appears here because it was detected by our daily top-EPS-revision-performer screen.
← All reports